Posted: 17 November 2023 The Victorian Medtech Skills and Devices Hub (VMH) has released a White Paper identifying the education and training needed to accelerate the growth of Victoria’s vibrant medtech industry. An initiative of the Victorian Government’s Australian Medtech…
Posted: 17 November 2023 Monash University Electrical and Computer Systems Engineering and Bionics Institute research teams have used cutting edge light technology invisible to the human eye to non-invasively image brains to help diagnose hearing impairments in infants and prescribe…
Posted: 14 November 2023 Telix today announces that the first patient has been dosed in the Company’s Phase III ProstACT GLOBAL study of its investigational prostate-specific membrane antigen (PSMA) targeting radio-antibody drug conjugate (rADC) therapy, TLX591 (177Lu-rosopatamab tetraxetan).…
Posted: 14 November 2023 Neuren Pharmaceuticals (ASX: NEU) today announced that all study visits are complete in its Phase 2 clinical trial of NNZ-2591 in Phelan-McDermid syndrome (PMS). Top-line results from the trial are expected to be available…
Posted: 14 November 2023 Neuren Pharmaceuticals (ASX: NEU) has been presented with the 2023 Australian Growth Company of the Year Award for Health and Life Sciences. Neuren CEO Jon Pilcher commented: “We were very pleased to be recognized…
Posted: 13 November 2023 Peter Mac scientists have been part of a nationwide push to get an important genetic test for blood cancer funded by Medicare. Approved by the federal government earlier this year and now funded in…
Posted: 13 November 2023 Monash University has been named Australia’s top research institution by The Australian in its annual list of the country’s top researchers and research institutions. Of the 250 fields of academic endeavour identified by The Australian Research Magazine…
Posted: 13 November 2023 Peter Mac will be part of a pioneering initiative driven by Moderna to bring together key Australian medical research institutes to form a mRNA Platform Incubator Network. The mRNA Platform Incubator Network aims to…
Posted: 13 November 2023 MedChem Australia will accelerate promising early-stage drug discovery projects towards clinical trials and, ultimately, create new medicines for a broad range of diseases. The first-of-its-kind national initiative connecting three of Australia’s top medicinal chemistry…
Posted: 13 November 2023 Researchers have invented an experimental wearable device that generates power from a user’s bending finger and can create and store memories, in a promising step towards health monitoring and other technologies. The innovation features…
Posted: 13 November 2023 VivaZome Therapeutics Pty Ltd (“VivaZome”) is presenting three posters at the 6th annual meeting of the Australian and New Zealand Society of Extracellular Vesicles (ANZSEV) being held this week in the Barossa Valley, South…
Posted: 9 November 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has successfully completed enrolment in its ATH434-201 Phase 2…